1. Home
  2. Directory
  3. Louisiana
  4. Raceland
  5. Pharmacist
  6. NPI Profile
  7. Prescriptions 1588092811

DANTE DOAN NGUYEN PHARMD., RPH.
Prescription History 1588092811
Pharmacist in Raceland, LA

NPI Status: Active since October 23, 2013

Contact Information

4858 HIGHWAY 1
RACELAND, LA
ZIP 70394
Phone: (985) 532-5527

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DANTE DOAN NGUYEN PHARMD., RPH., an active Pharmacist specialist practicing in Raceland, LA. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 305 documented patient claims. Among these therapy options, the most frequently utilized medication is Shingrix, which accounts for 125 claims alone.

Medication Index

A
B
S
T
No matching medications currently found on file.

Arexvy

Generic Formulation: Rsvpref3 Antigen/As01e/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 111
30-Day Fills 111.0
Days Supply 111
LA State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$323.81

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Boostrix Tdap

Generic Formulation: Diphth,pertuss(Acell),tet VacSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 31
30-Day Fills 31.0
Days Supply 31
LA State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills36.9
Peer Average Days Supply47
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,963.93 across this reporting matrix range.

Provider Avg Cost Per Claim

$63.35

State Avg Cost Per Claim

$65.81

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Shingrix

Generic Formulation: Varicella-Zoster Ge/As01b/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 125
30-Day Fills 125.0
Days Supply 125
LA State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills35.6
Peer Average Days Supply49
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 257.1% higher than the standard regional baseline profile for LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $27,198.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$217.59

State Avg Cost Per Claim

$200.96

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Twinrix

Generic Formulation: Hepatitis A And B Vaccine/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 38
30-Day Fills 38.0
Days Supply 38
LA State Average Benchmarks
Peer Average Claims170.0
Peer Average 30-Day Fills170.0
Peer Average Days Supply189
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 77.6% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,698.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$149.97

State Avg Cost Per Claim

$142.28

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DANTE DOAN NGUYEN PHARMD., RPH. provides transparency into local medical care patterns within Raceland, LA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Pharmacist** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.